BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xue K, MacLaren RE. Antisense oligonucleotide therapeutics in clinical trials for the treatment of inherited retinal diseases. Expert Opin Investig Drugs 2020;29:1163-70. [PMID: 32741234 DOI: 10.1080/13543784.2020.1804853] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Kantor A, McClements ME, Peddle CF, Fry LE, Salman A, Cehajic-Kapetanovic J, Xue K, MacLaren RE. CRISPR genome engineering for retinal diseases. Prog Mol Biol Transl Sci 2021;182:29-79. [PMID: 34175046 DOI: 10.1016/bs.pmbts.2021.01.024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
2 Iturriaga-Goyon E, Buentello-Volante B, Magaña-Guerrero FS, Garfias Y. Future Perspectives of Therapeutic, Diagnostic and Prognostic Aptamers in Eye Pathological Angiogenesis. Cells 2021;10:1455. [PMID: 34200613 DOI: 10.3390/cells10061455] [Reference Citation Analysis]
3 Testa F, Sodi A, Signorini S, Di Iorio V, Murro V, Brunetti-Pierri R, Valente EM, Karali M, Melillo P, Banfi S, Simonelli F. Spectrum of Disease Severity in Nonsyndromic Patients With Mutations in the CEP290 Gene: A Multicentric Longitudinal Study. Invest Ophthalmol Vis Sci 2021;62:1. [PMID: 34196655 DOI: 10.1167/iovs.62.9.1] [Reference Citation Analysis]
4 Fry LE, McClements ME, MacLaren RE. Analysis of Pathogenic Variants Correctable With CRISPR Base Editing Among Patients With Recessive Inherited Retinal Degeneration. JAMA Ophthalmol 2021;139:319-28. [PMID: 33507217 DOI: 10.1001/jamaophthalmol.2020.6418] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
5 Ross M, Ofri R. The future of retinal gene therapy: evolving from subretinal to intravitreal vector delivery. Neural Regen Res 2021;16:1751-9. [PMID: 33510064 DOI: 10.4103/1673-5374.306063] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
6 Quinn J, Musa A, Kantor A, McClements ME, Cehajic-Kapetanovic J, MacLaren RE, Xue K. Genome-Editing Strategies for Treating Human Retinal Degenerations. Hum Gene Ther 2021;32:247-59. [PMID: 32993386 DOI: 10.1089/hum.2020.231] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
7 Dinculescu A, Link BA, Saperstein DA. Retinal Gene Therapy for Usher Syndrome: Current Developments, Challenges, and Perspectives. Int Ophthalmol Clin 2021;61:109-24. [PMID: 34584048 DOI: 10.1097/IIO.0000000000000378] [Reference Citation Analysis]
8 Dong R, Zhang B, Tan B, Lin N. Long non-coding RNAs as the regulators and targets of macrophage M2 polarization. Life Sci 2021;266:118895. [PMID: 33310042 DOI: 10.1016/j.lfs.2020.118895] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Gupta A, Kafetzis KN, Tagalakis AD, Yu-Wai-Man C. RNA therapeutics in ophthalmology - translation to clinical trials. Exp Eye Res 2021;205:108482. [PMID: 33548256 DOI: 10.1016/j.exer.2021.108482] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
10 Piotter E, McClements ME, MacLaren RE. Therapy Approaches for Stargardt Disease. Biomolecules 2021;11:1179. [PMID: 34439845 DOI: 10.3390/biom11081179] [Reference Citation Analysis]
11 García Bohórquez B, Aller E, Rodríguez Muñoz A, Jaijo T, García García G, Millán JM. Updating the Genetic Landscape of Inherited Retinal Dystrophies. Front Cell Dev Biol 2021;9:645600. [PMID: 34327195 DOI: 10.3389/fcell.2021.645600] [Reference Citation Analysis]
12 Han RC, Fry LE, Kantor A, McClements ME, Xue K, MacLaren RE. Is subretinal AAV gene replacement still the only viable treatment option for choroideremia? Expert Opin Orphan Drugs 2021;9:13-24. [PMID: 34040899 DOI: 10.1080/21678707.2021.1882300] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Shughoury A, Ciulla TA, Bakall B, Pennesi ME, Kiss S, Cunningham ET Jr. Genes and Gene Therapy in Inherited Retinal Disease. Int Ophthalmol Clin 2021;61:3-45. [PMID: 34584043 DOI: 10.1097/IIO.0000000000000377] [Reference Citation Analysis]